Zhu Ming-qiang, Gong Chun-xiu, Wu Di, Huang Shu-yue, Cao Bing-yan
Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.
Zhonghua Er Ke Za Zhi. 2013 Mar;51(3):216-20.
To improve the accuracy of the diagnosis of the disease on the basis of the clinical features and genetic characteristics of patients with Silver Russell syndrome (SRS).
Patients diagnosed with SRS by Price criteria in 2006 to 2011 were reviewed for their clinical manifestations, physical signs, laboratory examinations and treatments.
Twenty cases with SRS were 0.08-12.17 yr old. Fifteen were male and 5 were female. The clinical characteristics included more than 80% of cases had postnatal growth retardation 100% (20/20), craniofacial dysmorphism 100% (20/20), small for gestation age 95% (19/20), asymmetry and thinning of the face and/or limbs 90% (18/20), fifth finger clinodactyly 80% (16/20), BMI < -2 SDS 80% (16/20). Their height was obviously lagging behind in the bone age. HD SDS/average of bone retardation was 3.08. The two patients with the chief complaint of external genital abnormalities would have aggressive surgical treatment and they did not use the growth hormone (GH) treatment. Only six patients had used the GH treatment. GH treatment at a dose of 0.1 IU/(kg·d) used in 2 cases achieved a growth velocity (GV) 8 - 11 cm/yr but in another 2 cases < 5 cm/yr. In genetic study, 6 patients were found to have 11p15 low methylation, 1 had low and high methylation, 1 had duplication, no relation between clinical and methylation of 11p15 was found.
There were great variations of clinical features in SRS characterized by small for gestation age and/or postnatal growth retardation, craniofacial dysmorphism, asymmetry of the face and/or limbs or ultrafine limbs, fifth finger clinodactyly. Severely low BMI was seen and height was obviously lagging behind in the bone age. The findings of laboratory tests and imaging of SRS were not specific. Some of SRS had 11p15 imprinting defects. The treatment of SRS is mainly symptomatic.
基于Silver-Russell综合征(SRS)患者的临床特征和基因特征,提高该疾病诊断的准确性。
回顾2006年至2011年依据Price标准诊断为SRS的患者的临床表现、体征、实验室检查及治疗情况。
20例SRS患者年龄为0.08 - 12.17岁。男性15例,女性5例。临床特征包括:超过80%的病例有出生后生长迟缓(100%,20/20)、颅面部畸形(100%,20/20)、小于胎龄儿(95%,19/20)、面部和/或肢体不对称及变细(90%,18/20)、第五指内弯(80%,16/20)、BMI < -2 SDS(80%,16/20)。其身高在骨龄方面明显滞后。身高SDS/骨龄迟缓平均值为3.08。以生殖器外观异常为主诉的2例患者将接受积极手术治疗,且未使用生长激素(GH)治疗。仅6例患者使用过GH治疗。2例使用剂量为0.1 IU/(kg·d) 的GH治疗,生长速度(GV)达到8 - 11 cm/年,但另外2例< 5 cm/年。在基因研究中,6例患者发现11p15低甲基化,1例有低甲基化和高甲基化,1例有重复,未发现11p15临床与甲基化之间的关联。
SRS的临床特征差异很大,表现为小于胎龄儿和/或出生后生长迟缓;颅面部畸形;面部和/或肢体不对称或肢体极细;第五指内弯。BMI严重偏低,身高在骨龄方面明显滞后。SRS的实验室检查和影像学检查结果不具特异性。部分SRS存在11p15印记缺陷。SRS的治疗主要是对症治疗。